Technical Analysis for CRSP - CRISPR Therapeutics AG

Grade Last Price % Change Price Change
grade C 49.22 -0.91% -0.45
CRSP closed down 0.91 percent on Tuesday, September 17, 2019, on 81 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CRSP trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 50 DMA Bullish -0.91%
MACD Bullish Centerline Cross Bullish -0.91%
180 Bullish Setup Bullish Swing Setup -0.91%
Expansion Pivot Buy Setup Bullish Swing Setup -0.91%
Stochastic Reached Overbought Strength -0.91%
BB Squeeze Ended Range Expansion -0.91%

Older signals for CRSP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Biology Immune System Genetics Serious Diseases Genetic Engineering Enzymes Genome Editing Cas9 CRISPR
Is CRSP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 53.97
52 Week Low 22.22
Average Volume 480,717
200-Day Moving Average 39.7279
50-Day Moving Average 48.2194
20-Day Moving Average 47.019
10-Day Moving Average 47.218
Average True Range 2.0406
ADX 16.73
+DI 22.9978
-DI 15.9669
Chandelier Exit (Long, 3 ATRs ) 44.1682
Chandelier Exit (Short, 3 ATRs ) 49.7289
Upper Bollinger Band 49.9595
Lower Bollinger Band 44.0785
Percent B (%b) 0.87
BandWidth 12.50771
MACD Line 0.1922
MACD Signal Line -0.2247
MACD Histogram 0.4168
Fundamentals Value
Market Cap 2 Billion
Num Shares 40.6 Million
EPS -1.41
Price-to-Earnings (P/E) Ratio -34.91
Price-to-Sales 73.74
Price-to-Book 3.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.76
Resistance 3 (R3) 51.83 51.06 51.33
Resistance 2 (R2) 51.06 50.41 51.02 51.19
Resistance 1 (R1) 50.14 50.02 49.76 50.07 51.05
Pivot Point 49.37 49.37 49.18 49.33 49.37
Support 1 (S1) 48.45 48.72 48.07 48.38 47.39
Support 2 (S2) 47.68 48.33 47.64 47.25
Support 3 (S3) 46.76 47.68 47.11
Support 4 (S4) 46.69